CN Stock MarketDetailed Quotes

688105 Nanjing Vazyme Biotech

Watchlist
  • 23.01
  • +0.13+0.57%
Market Closed May 31 15:00 CST
9.20BMarket Cap-605526P/E (TTM)

Nanjing Vazyme Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Nanjing Vazyme Biotech Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 27, 2024

Revenue(YoY)

301.57M

-0.21%
EPS(YoY)

0.01

+107.69%
Analyst Rating

Strong Buy

Jun 1, 2024

Nanjing Vazyme Biotech Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/Q3298.258M / 308.385M--
Aug 30, 20232023/Q2268.843M / 322.185M--
DatePeriodRevenue/EstimateEarnings Call
--2023/Q3298.258M / 308.385M--
Aug 30, 20232023/Q2268.843M / 322.185M--

Nanjing Vazyme Biotech Earnings Reports

  • 2024 First Quarter Report

    Apr 26 12:00 ET

  • 2023 Annual Report Summary

    Apr 26 12:00 ET

  • 2023 ANNUAL REPORT

    Apr 26 12:00 ET

  • Novi Zan Voluntary Disclosure Notice for the First Quarter of 2024 Earnings Forecast

    Apr 17 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 1, 2024

    Strong Buy

    • Strong Buy

      63.64%

    • Buy

      36.36%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg